SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062957
Filing Date
2023-11-13
Accepted
2023-11-13 16:14:26
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q allk-20230930.htm   iXBRL 10-Q 2202797
2 EX-31.1 allk-ex31_1.htm EX-31.1 19100
3 EX-31.2 allk-ex31_2.htm EX-31.2 19123
4 EX-32.1 allk-ex32_1.htm EX-32.1 10495
5 EX-32.2 allk-ex32_2.htm EX-32.2 10516
  Complete submission text file 0000950170-23-062957.txt   8534418

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allk-20230930_lab.xml EX-101.LAB 426921
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT allk-20230930_cal.xml EX-101.CAL 43867
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allk-20230930_pre.xml EX-101.PRE 302139
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT allk-20230930_def.xml EX-101.DEF 157913
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allk-20230930.xsd EX-101.SCH 46277
58 EXTRACTED XBRL INSTANCE DOCUMENT allk-20230930_htm.xml XML 1786942
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38582 | Film No.: 231398888
SIC: 2834 Pharmaceutical Preparations